Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY

Mid Cap | Pharmaceuticals & Drugs

1242.00

-3.50 (-0.28%)

< Home < Back

USFDA completes audit at Dr. Reddy's Lab’s IPDO

Date: 27-02-2020

US Food and Drug Administration (USFDA) has completed the audit of Dr. Reddy's Laboratories’ Integrated Product Development Organization (IPDO) at Medchal-Malkajgiri, Telangana and no Form 483 was issued at the closure of the audit.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.